What We Can Actually Conclude
We could not independently confirm a published randomized, controlled study evaluating the complete Nerve Armor capsule blend for clinical outcomes. This is the central evidence gap. Clinical studies on individual ingredients may guide questions, but are not interchangeable with product-level trials.
PEA: Evidence with Important Limits
The label lists 450 mg PEA per two-capsule serving. A systematic review and meta-analysis of PEA reported potential benefits across some chronic pain studies while noting very high heterogeneity and possible publication bias. Differences in study designs, participants, dose and delivery mean a result cannot be assigned to this specific capsule mixture.
Alpha-Lipoic Acid: Mixed Results
The label lists 150 mg ALA. NCCIH describes mixed findings among clinical studies on diabetic neuropathy and notes important limits in the available research. Some studies evaluate substantially different doses than Nerve Armor provides. The most careful reading is neither “proven ineffective” nor “proven to reverse nerve damage.”
What About Benfotiamine and Botanicals?
Benfotiamine, gotu kola and corydalis are included in the product and discussed in different nutrition or botanical research settings. We have not established that these ingredients, at the label amounts and in this precise combination, produce the seller-advertised nerve-pain outcomes.
Question Big Marketing Claims
Assertions about erasing nerve pain in a few days, regrowing nerves or a specific “termite cell” cause of neuropathy should not be treated as confirmed for this product. Neuropathy may involve multiple underlying conditions that require diagnosis.
If you have persistent or unexplained neurological symptoms, investigate the cause with a qualified clinician rather than relying on a supplement sales narrative.
Check the Current Seller Offer
Check price, shipping, subscription choices and refund conditions in the live checkout.
